نتایج جستجو برای: thin prep

تعداد نتایج: 130322  

Journal: :The Lancet. Infectious diseases 2016
Brooke E Nichols Charles A B Boucher Marc van der Valk Bart J A Rijnders David A M C van de Vijver

BACKGROUND Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine prevents HIV infections among men who have sex with men (MSM). PrEP can be given on a daily or intermittent basis. Unfortunately, PrEP is not reimbursed in most European countries. Cost-effectiveness analyses of PrEP among MSM in Europe are absent but are key for decision makers to decide upon PrEP implementation. MET...

2016
Rena C Patel Gaelen Stanford-Moore Josephine Odoyo Maria Pyra Imeldah Wakhungu Keerthana Anand Elizabeth A Bukusi Jared M Baeten Joelle M Brown

INTRODUCTION Since 2015, the World Health Organization recommends pre-exposure prophylaxis (PrEP) for all persons at substantial risk for HIV, including HIV-uninfected partners in serodiscordant relationships in resource-limited settings. As PrEP moves from clinical trials to real-world use, understanding facilitators of and barriers to PrEP initiation and adherence is critical to successful Pr...

2017
Bridget L. Draper Zaw Min Oo Zaw Win Thein Poe Poe Aung Vanessa Veronese Claire Ryan Myo Thant Chad Hughes Mark Stoové

INTRODUCTION HIV pre-exposure prophylaxis (PrEP) has emerged as a key component of contemporary HIV combination prevention strategies. To explore the local suitability of PrEP, country-specific acceptability studies are needed to inform potential PrEP implementation. In the context of Myanmar, in addition to resource constraints, HIV service access by gay men, other men who have sex with men, a...

2017
Rupa R Patel Leandro Mena Amy Nunn Timothy McBride Laura C Harrison Catherine E Oldenburg Jingxia Liu Kenneth H Mayer Philip A Chan

Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Mississippi; St. Louis, Missouri; Providence, Rhode Island) from 2014-2015. The outcome, PrEP utilization, was defined as patient PrEP use at three months. Multivariable logistic regression was performed...

2016
Iryna Zablotska Andrew E Grulich Nittaya Phanuphak Tarandeep Anand Surang Janyam Midnight Poonkasetwattana Rachel Baggaley Frits van Griensven Ying-Ru Lo

INTRODUCTION HIV epidemics in the Asia-Pacific region are concentrated among men who have sex with men (MSM) and other key populations. Pre-exposure prophylaxis (PrEP) is an effective HIV prevention intervention and could be a potential game changer in the region. We discuss the progress towards PrEP implementation in the Asia-Pacific region, including opportunities and barriers. DISCUSSION A...

Journal: :PLoS ONE 2007
Ume L. Abbas Roy M. Anderson John W. Mellors

BACKGROUND The potential impact of pre-exposure chemoprophylaxis (PrEP) on heterosexual transmission of HIV-1 infection in resource-limited settings is uncertain. METHODOLOGY/PRINCIPLE FINDINGS A deterministic mathematical model was used to simulate the effects of antiretroviral PrEP on an HIV-1 epidemic in sub-Saharan Africa under different scenarios (optimistic, neutral and pessimistic) bot...

ژورنال: :مجله دندانپزشکی 0
حسن رزمی h. razmi منصور صلواتی زاده m. salavati zadeh

تمایل و اندیشه استفاده از ترکیبات شیمیایی جهت رفع موانع انسدادی عاج دیواره کانال از دیرباز وجود داشته و در حال حاضر نیز تحقیقات و تلاشها در این زمینه بی نتیجه نبوده است؛ دراین رابطه rc-prep بهتر از بقیه مواد، دندانپزشکان را یاری نموده است. هدف از این مطالعه بررسی میزان قدرت دکلسیفیکاسیون دو نوع ماده chelating در مرحله آماده سازی کانال می باشد. در این مطالعه از 40 دندان کانین کشیده شده، استفاده ...

2017
Renee Heffron Kenneth Ngure Josephine Odoyo Nulu Bulya Edna Tindimwebwa Ting Hong Lara Kidoguchi Deborah Donnell Nelly R Mugo Elizabeth A Bukusi Elly Katabira Stephen Asiimwe Jennifer Morton Susan Morrison Harald Haugen Andrew Mujugira Jessica E Haberer Norma C Ware Monique A Wyatt Mark A Marzinke Lisa M Frenkel Connie Celum Jared M Baeten

Introduction: Pre-exposure prophylaxis (PrEP) can provide high protection against HIV infection and is a recommended intervention for HIV-negative persons with substantial HIV risk, such as individuals with a partner living with HIV.  Demonstration projects of PrEP have been conducted in diverse settings worldwide to illustrate practical examples of how PrEP can be delivered.  Methods: We evalu...

Journal: :AIDS 2013
David A M C van de Vijver Brooke E Nichols Ume L Abbas Charles A B Boucher Valentina Cambiano Jeffrey W Eaton Robert Glaubius Katrina Lythgoe John Mellors Andrew Phillips Kim C Sigaloff Timothy B Hallett

BACKGROUND Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 infections, but there is a concern that use of PrEP could increase HIV drug resistance resulting in loss of treatment options. We compared standardized outcomes from three independent mathematical models simulating the impact of PrEP on HIV transmission and drug resistance in sub-Saharan African cou...

2017
Stefanie J. Vaccher Christopher Gianacas David J. Templeton Isobel M. Poynten Bridget G. Haire Catriona Ooi Rosalind Foster Anna McNulty Andrew E. Grulich Iryna B. Zablotska

Introduction The effectiveness of daily pre-exposure prophylaxis (PrEP) is well established. However, there has been increasing interest in non-daily dosing schedules among gay and bisexual men (GBM). This paper explores preferences for PrEP dosing schedules among GBM at baseline in the PRELUDE demonstration project. Materials and methods Individuals at high-risk of HIV were enrolled in a fre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید